Progress toward a global group a streptococcal vaccine

Pediatric Infectious Disease Journal

Volumn 32, Issue 2, 2013, Pages 180-182

  Steer, Andrew C ^a   Dale, James B ^b   Carapetis, Jonathan R ^c  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

GROUP A STREPTOCOCCAL VACCINE; STREPTOCOCCUS VACCINE; UNCLASSIFIED DRUG;

DRUG EFFICACY; DRUG FORMULATION; DRUG SAFETY; GROUP A STREPTOCOCCAL INFECTION; HUMAN; NONHUMAN; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; REVIEW;

HUMANS; STREPTOCOCCAL INFECTIONS; STREPTOCOCCAL VACCINES; STREPTOCOCCUS PYOGENES; WORLD HEALTH;

EID: 84873036219     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e318281da11     Document Type: Review

References (18)

1. Miyake C Y, Gauvreau K, Tani LY, et al. Characteristics of children discharged from hospitals in the United states in 2000 with the diagnosis of acute rheumatic fever. Pediatrics. 2007;120:503-508.
2. Carapetis JR, Steer AC, Mulholland EK, et al. the global burden of group a streptococcal diseases. Lancet Infect Dis. 2005;5:685-694.
3. White AV, Hoy WE, McCredie DA. Childhood post-streptococcal glomerulonephritis as a risk factor for chronic renal disease in later life. Med J Aust. 2001;174:492-496.
4. Steer AC, Magor G, Jenney AW, et al. emm and C-repeat region molecular typing of beta-hemolytic streptococci in a tropical country: implications for vaccine development. J Clin Microbiol. 2009;47:2502-2509.
5. Steer AC, Batzloff MR, Mulholland K, et al. Group a streptococcal vaccines: facts versus fantasy. Curr Opin Infect Dis. 2009;22:544-552.
6. Mcneil SA, Halperin SA, Langley JM, et al. safety and immunogenicity of 26-valent group a streptococcus vaccine in healthy adult volunteers. Clin Infect Dis. 2005;41:1114-1122.
7. Kotloff KL, Corretti M, Palmer K, et al. safety and immunogenicity of a recombinant multi-valent group a streptococcal vaccine in healthy adults: phase 1 trial. JAMA. 2004;292:709-715.
8. Dale JB, Penfound TA, Chiang E Y, et al. new 30-valent M protein-based vaccine evokes cross-opsonic antibodies against non-vaccine sero-types of group a streptococci. Vaccine. 2011;29: 8175-8178.
9. Steer AC, Law I, Matatolu L, et al. Global emm type distribution of group a streptococci: systematic review and implications for vaccine development. Lancet Infect Dis. 2009;9:611-616.
10. Guilherme L, Faé KC, Higa F, et al. towards a vaccine against rheumatic fever. Clin Dev Immunol. 2006;13:125-132.
11. Batzloff MR, Hayman WA, Davies MR, et al. protection against group a streptococcus by immunization with J8-diphtheria toxoid: contribution of J8-and diphtheria toxoid-specifc antibodies to protection. J Infect Dis. 2003;187:1598-1608.
12. Batzloff M, Yan H, Davies M, et al. preclini-cal evaluation of a vaccine based on conserved region of M protein that prevents group a streptococcal infection. Indian J Med Res. 2004;119(suppl):104-107.
13. Cleary P P, Matsuka Y V, Huynh T, et al. immunization with C5a peptidase from either group a or B streptococci enhances clearance of group a streptococci from intranasally infected mice. Vaccine. 2004;22:4332-4341.
14. Salvadori LG, Blake MS, McCarty M, et al. Group a streptococcus-liposome eLisa antibody titers to group a polysaccharide and opsonophagocytic capabilities of the antibodies. J Infect Dis. 1995;171:593-600.
15. Kawabata S, Kunitomo E, Terao Y, et al. systemic and mucosal immunizations with fbronectin-binding protein FBp54 induce protective immune responses against streptococcus pyogenes challenge in mice. Infect Immun. 2001;69:924-930.
16. Fritzer A, Senn BM, Minh DB, et al. novel conserved group a streptococcal proteins identifed by the antigenome technology as vaccine candidates for a non-M protein-based vaccine. Infect Immun. 2010;78:4051-4067.
17. Massell BF, Honikman LH, Amezcua J. rheumatic fever following streptococcal vaccination. report of three cases. JAMA. 1969;207:1115-1119.
18. Proceedings of the tenth Global vaccine research Forum and parallel satellite symposia. available at: http://www.who.int/immunization/documents/ innovation/wHo-ivB-12.06/en/index.html. accessed June 26-29, 2011.